Back to Authors

Berenzon, Dmitry

A5112466992 | I4405269449

Mayo Clinic

Wake Forest University Health Sciences

Citations 1

Pegylated interferon alfa-2a for polycythemia vera or essential thrombocythemia resistant or intolerant to hydroxyurea

Blood | September 13, 2019 | Volume: 134 | Issue: 18 | Pages: 1498-1509

10.1182/blood.2019000428 | PMID 31515250

Yacoub et al report excellent responses to pegylated interferon alfa-2a in patients with hydroxyurea-resistant/intolerant polycythemia vera or essential thrombocythemia.